Corrigendum to “Zand L, Canetta P, Lafayette R, et al. An open-label pilot study of adrenocorticotrophic hormone in the treatment of IgA nephropathy at high risk of progression.” Kidney Int Rep. 2020;5:58–65

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Corrigenda
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056864/
https://www.ncbi.nlm.nih.gov/pubmed/32154464
http://dx.doi.org/10.1016/j.ekir.2020.01.024
_version_ 1783503547805990912
collection PubMed
description
format Online
Article
Text
id pubmed-7056864
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-70568642020-03-09 Corrigendum to “Zand L, Canetta P, Lafayette R, et al. An open-label pilot study of adrenocorticotrophic hormone in the treatment of IgA nephropathy at high risk of progression.” Kidney Int Rep. 2020;5:58–65 Kidney Int Rep Corrigenda Elsevier 2020-03-03 /pmc/articles/PMC7056864/ /pubmed/32154464 http://dx.doi.org/10.1016/j.ekir.2020.01.024 Text en © 2020 International Society of Nephrology. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Corrigenda
Corrigendum to “Zand L, Canetta P, Lafayette R, et al. An open-label pilot study of adrenocorticotrophic hormone in the treatment of IgA nephropathy at high risk of progression.” Kidney Int Rep. 2020;5:58–65
title Corrigendum to “Zand L, Canetta P, Lafayette R, et al. An open-label pilot study of adrenocorticotrophic hormone in the treatment of IgA nephropathy at high risk of progression.” Kidney Int Rep. 2020;5:58–65
title_full Corrigendum to “Zand L, Canetta P, Lafayette R, et al. An open-label pilot study of adrenocorticotrophic hormone in the treatment of IgA nephropathy at high risk of progression.” Kidney Int Rep. 2020;5:58–65
title_fullStr Corrigendum to “Zand L, Canetta P, Lafayette R, et al. An open-label pilot study of adrenocorticotrophic hormone in the treatment of IgA nephropathy at high risk of progression.” Kidney Int Rep. 2020;5:58–65
title_full_unstemmed Corrigendum to “Zand L, Canetta P, Lafayette R, et al. An open-label pilot study of adrenocorticotrophic hormone in the treatment of IgA nephropathy at high risk of progression.” Kidney Int Rep. 2020;5:58–65
title_short Corrigendum to “Zand L, Canetta P, Lafayette R, et al. An open-label pilot study of adrenocorticotrophic hormone in the treatment of IgA nephropathy at high risk of progression.” Kidney Int Rep. 2020;5:58–65
title_sort corrigendum to “zand l, canetta p, lafayette r, et al. an open-label pilot study of adrenocorticotrophic hormone in the treatment of iga nephropathy at high risk of progression.” kidney int rep. 2020;5:58–65
topic Corrigenda
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056864/
https://www.ncbi.nlm.nih.gov/pubmed/32154464
http://dx.doi.org/10.1016/j.ekir.2020.01.024

Ejemplares similares